SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.67 -0.51
(-0.53%)

EUR-INR

111.19 -0.10
(-0.09%)

GBP-INR

128.70 -0.19
(-0.14%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Proventus Agrocom Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

78870

INE0ONE01016

354.1878997

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PROV

70.78

455.85

EPS(TTM)

Face Value()

Div & Yield %

18.65

Back

Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter

Feb 02,2026

Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	72.54	73.29	-1
OPM %	4.26	5.44	-
PBDT	2.17	6.55	-67
PBT	1.61	6.07	-73
NP	0.31	5.36	-94

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.67 -0.51 (-0.53%)

111.19 -0.10 (-0.09%)

128.70 -0.19 (-0.14%)

0.60 0.00 (0.12%)